Lansoprazol Viatris

Lansoprazole, the active ingredient in Lansoprazol Viatris, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and as part of Helicobacter pylori eradication regimens in adult patients.

GNH USA supplies Lansoprazol Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch.

Lansoprazole is used to treat acid‑related disorders by decreasing gastric acid secretion.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by maintaining a higher gastric pH. - Peptic ulcer disease: promotes healing of gastric and duodenal ulcers through sustained acid suppression. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic combinations by creating a less acidic gastric environment.

Lansoprazole may cause adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often resolving without treatment. - Diarrhea: loose stools that may be transient. - Nausea: feeling of stomach upset, sometimes accompanied by vomiting. - Abdominal pain: cramping or discomfort in the stomach area.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, difficulty breathing, rash. - Clostridioides difficile infection: severe diarrhea with abdominal pain. - Low serum magnesium (hypomagnesemia): muscle cramps, irregular heartbeat. - Liver enzyme elevation: signs of hepatic injury such as jaundice.

Before prescribing Lansoprazole, clinicians should evaluate several safety considerations. - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate for CYP2C19 interactions: co‑administration with certain drugs can alter exposure. - Monitor magnesium levels: prolonged use may lead to hypomagnesemia. - Use with caution in the elderly: increased risk of fractures and infections. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lansoprazole can affect the pharmacokinetics of several medicines; interactions are categorized by clinical relevance.

Major Interactions (Avoid): - Clarithromycin: markedly increases lansoprazole plasma concentrations. - Ketoconazole: reduced absorption due to higher gastric pH. - Atazanavir: decreased antiviral efficacy from impaired dissolution.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of anticoagulant effect. - Digoxin: possible increase in serum levels. - Methotrexate: reduced renal clearance may raise toxicity risk.